The present invention relates to compounds effective in treating hepatotoxicity and fatty liver diseases and uses thereof. The present compound is represented by Formula (II), which has the formula: R1—O—X—(CH2)m—X—O—R2, wherein: each X is —C(═O)—； R1 is a C1-C18 alkyl polyol: R2 is a saccharide group of formula (G)p； G is a monosaccharide residue, where (i) at least one of the —OH groups in (G)p is substituted by a halogen atom, and (ii) the saccharide group of formula (G)p is linked to —O— through a —CH2 group； p is 1 or 2； and m is 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10.
